{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T23:49:31Z","timestamp":1787701771462,"version":"build-2784847793"},"reference-count":41,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:00:00Z","timestamp":1679443200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Macrolide (MLR) and fluoroquinolone (FQR) resistance in Mycoplasma genitalium (MG) has recently become a major problem worldwide. The available data on the prevalence of MLR and FQR in MG in Russia are limited. In this study, we aimed to evaluate the prevalence and pattern of mutations in 213 MG-positive urogenital swabs from patients in Moscow between March 2021 and March 2022. MLR- and FQR-associated mutations were searched in 23S rRNA as well as in the parC and gyrA genes using Sanger sequencing. The prevalence of MLR was 55\/213 (26%), with A2059G and A2058G substitutions being the two most common variants (36\/55, 65%, and 19\/55, 35%, respectively). FQR detection showed 17% (37\/213); two major variants were D84N (20\/37, 54%) and S80I (12\/37, 32.4%) and three minor variants were S80N (3\/37, 8.1%), D84G (1\/37, 2.7%), and D84Y (1\/37, 2.7%). Fifteen of the fifty-five MLR cases (27%) simultaneously harbored FQR. This study revealed the high frequency of MLR and FQR. We conclude that the improvement of patient examination algorithms and therapeutic approaches should be combined with the routine monitoring of antibiotic resistance based on the sensitivity profiles presented. Such a complex approach will be essential for restraining the development of treatment resistance in MG.<\/jats:p>","DOI":"10.3390\/pathogens12030496","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T07:09:31Z","timestamp":1679468971000},"page":"496","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Genetic Determinants of Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium and Their Prevalence in Moscow, Russia"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3720-1004","authenticated-orcid":false,"given":"Inna Alexandrovna","family":"Edelstein","sequence":"first","affiliation":[{"name":"Institute of Antimicrobial Chemotherapy, Smolensk State Medical University of the Ministry of Health of the Russian Federation, 214019 Smolensk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0399-1167","authenticated-orcid":false,"given":"Alexandr Evgenjevich","family":"Guschin","sequence":"additional","affiliation":[{"name":"Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, 125008 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2223-193X","authenticated-orcid":false,"given":"Andrew Vyacheslavovich","family":"Romanov","sequence":"additional","affiliation":[{"name":"Institute of Antimicrobial Chemotherapy, Smolensk State Medical University of the Ministry of Health of the Russian Federation, 214019 Smolensk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5613-6482","authenticated-orcid":false,"given":"Ekaterina Sergeevna","family":"Negasheva","sequence":"additional","affiliation":[{"name":"Moscow Scientific and Practical Center of Dermatovenerology and Cosmetology, 125008 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8728-1113","authenticated-orcid":false,"given":"Roman Sergeevich","family":"Kozlov","sequence":"additional","affiliation":[{"name":"Institute of Antimicrobial Chemotherapy, Smolensk State Medical University of the Ministry of Health of the Russian Federation, 214019 Smolensk, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,3,22]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (2022, September 09). Global Health Sector Strategies on, Respectively, HIV, Viral Hepatitis and Sexually Transmitted Infections for the Period 2022\u20132030. Available online: https:\/\/www.who.int\/publications\/m\/item\/global-health-sector-strategies-on-respectively--hiv-viral-hepatitis-and-stis-for-2022-2030."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"106253","DOI":"10.1016\/j.ijantimicag.2020.106253","article-title":"Antimicrobial Drug Resistance Mechanisms among Mollicutes","volume":"57","author":"Chernova","year":"2021","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"105911","DOI":"10.1016\/j.ijantimicag.2020.105911","article-title":"Molecular Basis of Antimicrobial Resistance in Mycoplasma genitalium","volume":"55","author":"Braam","year":"2020","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2340\/00015555-0929","article-title":"Guidelines for the Laboratory Diagnosis of Mycoplasma genitalium Infections in East European Countries","volume":"90","author":"Shipitsyna","year":"2010","journal-title":"Acta Derm. Venereol."},{"key":"ref_5","unstructured":"Savelieva, G.M., Sukhikh, G.T., and Serov, V.N. (2022). Obstetrics: National Guidelines, GEOTAR-Media."},{"key":"ref_6","unstructured":"Savelieva, G.M., Serov, V.N., and Radzinsky, V.E. (2022). Gynecology: National Guidelines, GEOTAR-Media."},{"key":"ref_7","unstructured":"(2022, September 09). Urogenital Diseases Caused by Mycoplasma genitalium. Clinical Guidelines, Available online: https:\/\/cr.minzdrav.gov.ru\/schema\/216_1."},{"key":"ref_8","unstructured":"Federal Clinical Guidelines (2015). Dermatovenereology 2015, Business Express."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1177\/0956462418764482","article-title":"Prevalence of Mycoplasma Genitalium and Mutations Associated with Macrolide and Fluoroquinolone Resistance in Finland","volume":"29","author":"Hokynar","year":"2018","journal-title":"Int. J. STD AIDS"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e01084-20","DOI":"10.1128\/JCM.01084-20","article-title":"Prevalence of Mycoplasma Genitalium and Antibiotic Resistance-Associated Mutations in Patients at a Sexually Transmitted Infection Clinic in Iceland, and Comparison of the s-Diamgtv and Aptima Mycoplasma genitalium Assays for Diagnosis","volume":"58","author":"Golparian","year":"2020","journal-title":"J. Clin. Microbiol."},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Guschin, A., Ryzhikh, P., Rumyantseva, T., Gomberg, M., and Unemo, M. (2015). Treatment Efficacy, Treatment Failures and Selection of Macrolide Resistance in Patients with High Load of Mycoplasma genitalium during Treatment of Male Urethritis with Josamycin. BMC Infect. Dis., 15.","DOI":"10.1186\/s12879-015-0781-7"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1136\/sextrans-2019-054124","article-title":"Prevalence of Mycoplasma genitalium and Macrolide Resistance among Asymptomatic People Visiting a Point of Care Service for Rapid STI Screening: A Cross-Sectional Study","volume":"96","author":"Esperalba","year":"2020","journal-title":"Sex. Transm. Infect."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/0956462419890737","article-title":"Mycoplasma genitalium and Antimicrobial Resistance in Europe: A Comprehensive Review","volume":"31","author":"Esperalba","year":"2020","journal-title":"Int. J. STD AIDS"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Hamasuna, R., Le, P.T., Kutsuna, S., Furubayashi, K., Matsumoto, M., Ohmagari, N., Fujimoto, N., Matsumoto, T., and Jensen, J.S. (2018). Mutations in Parc and Gyra of Moxifloxacin-Resistant and Susceptible Mycoplasma genitalium Strains. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0198355"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/apm.12792","article-title":"Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium in Two Swedish Counties, 2011\u20132015","volume":"126","author":"Hadad","year":"2018","journal-title":"APMIS"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1099\/mic.0.000830","article-title":"Mycoplasma genitalium: A Review","volume":"166","author":"Gnanadurai","year":"2020","journal-title":"Microbiology"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e00886-19","DOI":"10.1128\/JCM.00886-19","article-title":"Multicenter Clinical Evaluation of a Novel Multiplex Real-Time PCR (QPCR) Assay for Detection of Fluoroquinolone Resistance in Mycoplasma genitalium","volume":"57","author":"Bodiyabadu","year":"2019","journal-title":"J. Clin. Microbiol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1093\/cid\/civ644","article-title":"The Efficacy of Azithromycin for the Treatment of Genital Mycoplasma genitalium: A Systematic Review and Meta-Analysis","volume":"61","author":"Lau","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1177\/0956462416688562","article-title":"Meta-Analysis of the Efficacy of Moxifloxacin in Treating Mycoplasma genitalium Infection","volume":"28","author":"Li","year":"2017","journal-title":"Int. J. STD AIDS"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"119","DOI":"10.36488\/cmac.2019.2.119-124","article-title":"AMRcloud: A New Paradigm in Monitoring of Antibiotic Resistance","volume":"21","author":"Kuzmenkov","year":"2019","journal-title":"Clin. Microbiol. Antimicrob. Chemother."},{"key":"ref_21","unstructured":"(2016). Federal Clinical Recommendations for Patients with Urogenital Diseases Caused by Mycoplasma genitalium. Obstet. Gynecol., 4, 64\u201369."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2147\/IDR.S105469","article-title":"Mycoplasma genitalium Infections: Current Treatment Options and Resistance Issues","volume":"10","author":"Sethi","year":"2017","journal-title":"Infect. Drug Resist."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/jac\/dkv136","article-title":"High Levels of Macrolide Resistance-Associated Mutations in Mycoplasma genitalium Warrant Antibiotic Susceptibility-Guided Treatment","volume":"70","author":"Nijhuis","year":"2015","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_24","first-page":"31","article-title":"Comparative Analysis of Modern Approaches to the Treatment of m. Genitalium Infection in Clinical Practice","volume":"64","author":"Kisina","year":"2019","journal-title":"Antibiot. I Khimioterapiya"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S1473-3099(20)30154-7","article-title":"Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: A systematic review and meta-analysis","volume":"20","author":"Machalek","year":"2020","journal-title":"Lancet Infect. Dis."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3201\/eid2305.161745","article-title":"Increasing Macrolide and Fluoroquinolone Resistance in Mycoplasma genitalium","volume":"23","author":"Murray","year":"2017","journal-title":"Emerg. Infect. Dis."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"001257","DOI":"10.1099\/jmm.0.001257","article-title":"Detection of ParC Gene Mutations Associated with Quinolone Resistance in Mycoplasma genitalium: Evaluation of a Multiplex Real-Time PCR Assay","volume":"70","author":"Bodiyabadu","year":"2021","journal-title":"J. Med. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.3201\/eid2209.160446","article-title":"Fluoroquinolone-Resistant Mycoplasma Genitalium, Southwestern France","volume":"22","author":"Pereyre","year":"2016","journal-title":"Emerg. Infect. Dis."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ijantimicag.2010.05.011","article-title":"Emergence of Clinical Strains of Mycoplasma genitalium Harbouring Alterations in ParC Associated with Fluoroquinolone Resistance","volume":"36","author":"Shimada","year":"2010","journal-title":"Int. J. Antimicrob. Agents"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1086\/496983","article-title":"In Vitro Activity of Fluoroquinolones against Mycoplasma genitalium and Their Bacteriological Efficacy for Treatment of m. Genitalium-Positive Nongonococcal Urethritis in Men","volume":"41","author":"Yasuda","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00007435-200108000-00010","article-title":"Association of Mycoplasma genitalium Persistence in the Urethra with Recurrence of Nongonococcal Urethritis","volume":"28","author":"Maeda","year":"2001","journal-title":"Sex. Transm. Dis."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1258\/ijsa.2008.008038","article-title":"Azithromycin and Moxifloxacin for Microbiological Cure of Mycoplasma genitalium Infection: An Open Study","volume":"19","author":"Jernberg","year":"2008","journal-title":"Int. J. STD AIDS"},{"key":"ref_33","unstructured":"Potekaev, N.N., Dolja, O.V., Zukova, O.V., Kisina, V.I., Guschin, A.E., Gomberg, M.A., Frigo, N.V., Zabirov, K.I., Kovalyk, V.P., and Romanova, I.V. (2022, September 09). Department of Health of the Moscow City. Urogenital Diseases, caused by Mycoplasma genitalium. 4\u201320. Clinical Guidelines. Available online: https:\/\/mosgorzdrav.ru."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/nyas.12830","article-title":"Mechanisms of Drug Resistance: Quinolone Resistance","volume":"1354","author":"Hooper","year":"2015","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.tim.2014.04.007","article-title":"Fluoroquinolone Resistance: Mechanisms, Impact on Bacteria, and Role in Evolutionary Success","volume":"22","author":"Redgrave","year":"2014","journal-title":"Trends Microbiol."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Shipitsyna, E., Rumyantseva, T., Golparian, D., Khayrullina, G., Lagos, A.C., Edelstein, I., Joers, K., Jensen, J.S., Savicheva, A., and Rudneva, N. (2017). Prevalence of Macrolide and Fluoroquinolone Resistance-Mediating Mutations in Mycoplasma genitalium in Five Cities in Russia and Estonia. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0175763"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s10096-021-04170-0","article-title":"Clinical Evaluation of Commercial PCR Assays for Antimicrobal Resistance in Mycoplasma genitalium and Estimation of Resistance-Mediated Mutation Prevalence in Moscow and Moscow Region","volume":"40","author":"Shedko","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Rachina, S.A., Kozlov, R.S., Kurkova, A.A., Portnyagina, U.S., Palyutin, S.C., Khokhlov, A.L., Reshetko, O.V., Zhuravleva, M.V., and Palagin, I.S. (2022). On Behalf Of Russian Working Group Of The Project. Antimicrobial Dispensing Practice in Community Pharmacies in Russia during the COVID-19 Pandemic. Antibiotics, 11.","DOI":"10.3390\/antibiotics11050586"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Fookes, M.C., Hadfield, J., Harris, S.R., Parmar, S., Unemo, M., Jensen, J.S., and Thomson, N.R. (2017). Mycoplasma genitalium: Whole genome sequence analysis, recombination and population structure. BMC Genom., 18.","DOI":"10.1186\/s12864-017-4399-6"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"55","DOI":"10.17116\/klinderma20212001155","article-title":"Localization Features of Sexually Transmitted Infections in Subjectively Asymptomatic Men Who Have Sex with Men","volume":"20","author":"Tyulenev","year":"2021","journal-title":"Klin. Dermatol. I Venerol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"802","DOI":"10.17116\/klinderma202019061802","article-title":"Sexually Transmitted Infections in Asymptomatic Men Who Have Sex with Men","volume":"19","author":"Tyulenev","year":"2020","journal-title":"Klin. Dermatol. I Venerol."}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/3\/496\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T19:00:14Z","timestamp":1760122814000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/12\/3\/496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,22]]},"references-count":41,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2023,3]]}},"alternative-id":["pathogens12030496"],"URL":"https:\/\/doi.org\/10.3390\/pathogens12030496","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,22]]}}}